1 Min Read
Feb 6 (Reuters) - Orient Pharma Co Ltd :
* Says it got market license in U.S for its hypolipidemic generic drug named Pitavastatin
Source text in Chinese: goo.gl/bQqaTp
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.